Download: Program slides
Topics
This patient education program will cover:
- Watch and wait (active surveillance) for CLL
- Current and emerging therapies
- Managing symptoms and side effects at home
- How to collaborate with your healthcare team when making treatment decisions
Key Insights: Treating Chronic Lymphocytic Leukemia (CLL)
Speaker
Mazyar Shadman, MD, MPH
Professor, Clinical Research Division
Medical Director, Cellular Immunotherapy and the Bezos Family Immunotherapy Clinic
Innovators Network Endowed Chair
Deputy Chief Medical Officer (Malignant Hematology/BMT/Immunotherapy)
Fred Hutchinson Cancer Center
Professor of Medicine, Division of Hematology and Medical Oncology
University of Washington
Seattle, WA
Program Support
This program is supported by AbbVie Inc., AstraZeneca Pharmaceuticals LP, BeOne Medicines, Eli Lilly and Company, and Genentech, a member of the Roche Group.